<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">RSX</journal-id>
<journal-id journal-id-type="hwp">sprsx</journal-id>
<journal-id journal-id-type="nlm-ta">Reprod Sci</journal-id>
<journal-title>Reproductive Sciences</journal-title>
<issn pub-type="ppub">1933-7191</issn>
<issn pub-type="epub">1933-7205</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1933719111424434</article-id>
<article-id pub-id-type="publisher-id">10.1177_1933719111424434</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Effects of Preeclamptic Plasma on Potassium Currents of Human Umbilical Vein Endothelial Cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Watanapa</surname>
<given-names>Wattana B.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-1933719111424434">1</xref>
<xref ref-type="corresp" rid="corresp1-1933719111424434"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Theerathananon</surname>
<given-names>Wuttinan</given-names>
</name>
<degrees>MSc</degrees>
<xref ref-type="aff" rid="aff1-1933719111424434">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Akarasereenont</surname>
<given-names>Pravit</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff2-1933719111424434">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Techatraisak</surname>
<given-names>Kitirat</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff3-1933719111424434">3</xref>
</contrib>
</contrib-group>
<aff id="aff1-1933719111424434">
<label>1</label>Department of Physiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand</aff>
<aff id="aff2-1933719111424434">
<label>2</label>Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand</aff>
<aff id="aff3-1933719111424434">
<label>3</label>Department of Obstetrics–Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand</aff>
<author-notes>
<corresp id="corresp1-1933719111424434">Wattana B. Watanapa, Department of Physiology, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Prannok Road, Bangkok-Noi, Bangkok 10700, Thailand Email: <email>siwwt@mahidol.ac.th</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2012</year>
</pub-date>
<volume>19</volume>
<issue>4</issue>
<fpage>391</fpage>
<lpage>399</lpage>
<permissions>
<copyright-statement>© Society for Gynecologic Investigation 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Society for Gynecologic Investigation</copyright-holder>
</permissions>
<abstract>
<p>Endothelial cell (EC) dysfunction in preeclampsia (PE) may be mediated by humoral factors secreted by placenta, thereby affecting the EC vasoactive compound production. Possible targets of these factors include potassium channels, which are important in EC membrane potential control, calcium influx, and vasoactive compound release. Alterations in potassium channel function may thus contribute to the pathogenesis of PE. The present study compared the effects of 10% plasma from PE, normal pregnant (NP), or nonpregnant women (NS) on potassium currents of human umbilical vein ECs (HUVECs), using whole-cell patch clamp technique, with HUVECs in conventional culture medium (10% fetal bovine serum) as controls. Cells of all groups were similar in morphology and whole-cell capacitance. The fraction of cells with inward rectifier potassium channel (IRK) current in PE plasma (41.2%) was significantly lower than those in NP and NS plasmas (76.9% and 59.1%, respectively), although the IRK current density was similar among groups. The outward current components included the calcium-sensitive potassium channels (K<sub>Ca</sub>) and were partially blocked by 100 nmol/L apamin and 200 nmol/L iberiotoxin. The fraction with outward current in PE plasma (100%) was significantly higher than those in NP and NS plasmas (76.9% and 81.8%). The findings indicate inhibition of IRK expression by PE plasma in HUVEC culture, while K<sub>Ca</sub> expression may be facilitated probably as a compensatory response to diminished IRK. These data suggest that potassium channels may be a target of the pathogenic factor/factors in the plasma of patients with PE and may play roles in the pathogenesis of this condition.</p>
</abstract>
<kwd-group>
<kwd>hypertensive disorder of pregnancy</kwd>
<kwd>inward rectifier potassium channel</kwd>
<kwd>calcium-sensitive potassium channels</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1933719111424434">
<title>Introduction</title>
<p>Preeclampsia (PE), a hypertensive disorder of pregnancy, is an important cause of maternal and fetal morbidity and mortality worldwide,<sup>
<xref ref-type="bibr" rid="bibr1-1933719111424434">1</xref>
<xref ref-type="bibr" rid="bibr2-1933719111424434"/>–<xref ref-type="bibr" rid="bibr3-1933719111424434">3</xref>
</sup> due to its association with severe complications in the mother, such as cerebral hemorrhage, lung edema, ischemic heart disease, and liver hemorrhage and rupture.<sup>
<xref ref-type="bibr" rid="bibr1-1933719111424434">1</xref>
<xref ref-type="bibr" rid="bibr2-1933719111424434"/>
<xref ref-type="bibr" rid="bibr3-1933719111424434"/>–<xref ref-type="bibr" rid="bibr4-1933719111424434">4</xref>
</sup> Overwhelming evidence has indicated that endothelial dysfunction plays a crucial role in the pathogenesis of PE.<sup>
<xref ref-type="bibr" rid="bibr4-1933719111424434">4</xref>
<xref ref-type="bibr" rid="bibr5-1933719111424434"/>
<xref ref-type="bibr" rid="bibr6-1933719111424434"/>
<xref ref-type="bibr" rid="bibr7-1933719111424434"/>
<xref ref-type="bibr" rid="bibr8-1933719111424434"/>
<xref ref-type="bibr" rid="bibr9-1933719111424434"/>
<xref ref-type="bibr" rid="bibr10-1933719111424434"/>
<xref ref-type="bibr" rid="bibr11-1933719111424434"/>
<xref ref-type="bibr" rid="bibr12-1933719111424434"/>
<xref ref-type="bibr" rid="bibr13-1933719111424434"/>–<xref ref-type="bibr" rid="bibr14-1933719111424434">14</xref>
</sup> One hypothesis for the pathogenesis of PE is the presence of 1 or more putative circulating factors secreted from placenta, which may cause generalized endothelial cell (EC) dysfunction and consequently vasoconstriction.<sup>
<xref ref-type="bibr" rid="bibr4-1933719111424434">4</xref>
</sup> The existence of factors in either plasma or sera from patients with PE capable of altering endothelial functions has been supported by several studies.<sup>
<xref ref-type="bibr" rid="bibr15-1933719111424434">15</xref>
<xref ref-type="bibr" rid="bibr16-1933719111424434"/>
<xref ref-type="bibr" rid="bibr17-1933719111424434"/>
<xref ref-type="bibr" rid="bibr18-1933719111424434"/>
<xref ref-type="bibr" rid="bibr19-1933719111424434"/>
<xref ref-type="bibr" rid="bibr20-1933719111424434"/>–<xref ref-type="bibr" rid="bibr21-1933719111424434">21</xref>
</sup>
</p>
<p>Potential targets of the pathogenic vasoconstricting factors may include any endothelial proteins involved in vasoconstriction, vasodilation, release of vasoactive substances, and/or regulation of these processes. One group of such possible target proteins are ion channels, which are membrane proteins that regulate rapid transport of ions. Probably the most important functional role of ion channels in ECs is their involvement in Ca<sup>2+</sup> signaling that leads to the production and release of vasoactive agents.<sup>
<xref ref-type="bibr" rid="bibr22-1933719111424434">22</xref>
<xref ref-type="bibr" rid="bibr23-1933719111424434"/>–<xref ref-type="bibr" rid="bibr24-1933719111424434">24</xref>
</sup> It is possible that alterations in 1 or more endothelial ion channels and their functions can cause changes in vasoactive substance release or inappropriate vasoconstriction seen in patients with PE.</p>
<p>There have been few studies on ion channel functions in PE. Human umbilical vein ECs (HUVECs) obtained from patients with PE were reported to have slightly elevated basal intracellular calcium concentration, while agonist-stimulated Ca<sup>2+</sup> entry was reduced.<sup>
<xref ref-type="bibr" rid="bibr25-1933719111424434">25</xref>
</sup> In another study, the density of stretch-activated cation channel in ECs from PE was 2-fold higher than that from normal pregnancy.<sup>
<xref ref-type="bibr" rid="bibr26-1933719111424434">26</xref>
</sup> Finally, incubation of HUVECs with plasma from patients with PE increased calcium oscillation,<sup>
<xref ref-type="bibr" rid="bibr27-1933719111424434">27</xref>
</sup> but the physiologic basis of this phenomenon has not been elucidated.</p>
<p>Potassium channels in ECs are responsible for maintaining resting membrane potential which sets the magnitude of the driving force for transmembrane Ca<sup>2+</sup> influx. Types of potassium channels in ECs reported previously are the inward rectifier potassium channel (IRK), calcium-activated potassium channels (K<sub>Ca</sub>), and adenosine triphosphate (ATP)–sensitive potassium channel (K<sub>ATP</sub>).<sup>
<xref ref-type="bibr" rid="bibr22-1933719111424434">22</xref>
</sup> The aim of the present study was to investigate whether preeclamptic plasma, presumably containing putative vasoconstrictive factors, could alter potassium current amplitude and/or properties in HUVECs, when compared with plasma from normal pregnant (NP) and nonpregnant women (NS).</p>
</sec>
<sec id="section2-1933719111424434">
<title>Materials and Methods</title>
<sec id="section3-1933719111424434">
<title>Experimental Design</title>
<p>Endothelial cells obtained from normal human umbilical veins were divided into 4 cell groups: fetal bovine serum (FBS) treated, NS treated, NP treated, or PE treated. All cells were kept in identical conditions. Fetal bovine serum–treated cell group was kept in the culture medium that had 10% FBS. In NS-, NP- and PE-treated cell groups, 10% of the plasma from NS participants, NP participants, and PE patients, respectively, were substituted for the 10% FBS. Electrophysiological studies were done after 5 hours, and within 14 hours, of plating (and plasma exposure). The study was conducted with the approval of the Ethical Clearance Committee on Human Rights Related to Research Involving Human Subjects, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand.</p>
<p>Existing reports addressing circulating factors have preferred either plasma or serum for various reasons. In our preliminary trials, however, cultured HUVECs only survived in culture medium with 10% plasma from normal participants but failed to grow in 10% serum from the same blood collection. Therefore, plasma was preferred in the present study.</p>
</sec>
<sec id="section4-1933719111424434">
<title>Plasma Donors</title>
<p>The age range of all plasma donors was between 25 to 32 years of age. Participants with PE (PE) were pregnant women whose blood pressures were <underline>≥</underline>140/90 mm Hg after 20 weeks of gestation, with positive albumin in the urinary examination. Exclusion criteria are as follows: (1) a history of hypertension, diabetes mellitus, renal, and/or cardiovascular disease prior to the 20th week of gestation; (2) the high blood pressure did not reverse to normal after delivery; (3) receiving antihypertensive medication or MgSO<sub>4</sub>, or any medication with known effects on ion channels, before or at the time of sample collection. Normal Pregnant Participants (NP) were pregnant woman volunteers who did not have a history of any disease nor receive any medication during pregnancy. They were age- and gestational age-matched with PE participants. Nonpregnant participants (NS) were apparently normal women, without a history of any disease and did not take any contraceptive pills or other medication. They were also age-matched with PE participants. <xref ref-type="table" rid="table1-1933719111424434">Table 1</xref> summarizes the characteristics of all plasma donors. Informed consent was obtained from every participant before blood sampling.</p>
<table-wrap id="table1-1933719111424434" position="float">
<label>Table 1.</label>
<caption>
<p>Clinical Characteristics of Plasma Donors<sup><xref ref-type="table-fn" rid="table-fn2-1933719111424434">a</xref></sup>
</p>
</caption>
<graphic alternate-form-of="table1-1933719111424434" xlink:href="10.1177_1933719111424434-table1.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th colspan="3">Participants</th>
</tr>
<tr>
<th>
</th>
<th>PE</th>
<th>NP</th>
<th>NS</th>
</tr>
</thead>
<tbody>
<tr>
<td>Number of participants</td>
<td>5</td>
<td>5</td>
<td>4</td>
</tr>
<tr>
<td>Weight (kg)</td>
<td>77.9 ± 3.4</td>
<td>60.0 ± 3.3<sup><xref ref-type="table-fn" rid="table-fn3-1933719111424434">b</xref></sup>
</td>
<td>45.3 ± 1.7<sup><xref ref-type="table-fn" rid="table-fn3-1933719111424434">b</xref>,<xref ref-type="table-fn" rid="table-fn4-1933719111424434">c</xref></sup>
</td>
</tr>
<tr>
<td>Age (yr)</td>
<td>26.8 ± 1.3</td>
<td>23.4 ± 1.4</td>
<td>27.5 ± 1.3</td>
</tr>
<tr>
<td>Gestational age<sup><xref ref-type="table-fn" rid="table-fn5-1933719111424434">d</xref>,<xref ref-type="table-fn" rid="table-fn6-1933719111424434">e</xref></sup> (wk)</td>
<td>34.5 ± 1.6</td>
<td>31.2 ± 0.5<sup><xref ref-type="table-fn" rid="table-fn3-1933719111424434">b</xref></sup>
</td>
<td>−</td>
</tr>
<tr>
<td>Systolic BP (mm Hg)</td>
<td>138.0 ± 2.0</td>
<td>114.0 ± 2.5<sup><xref ref-type="table-fn" rid="table-fn3-1933719111424434">b</xref></sup>
</td>
<td>108.8 ± 1.3<sup><xref ref-type="table-fn" rid="table-fn3-1933719111424434">b</xref></sup>
</td>
</tr>
<tr>
<td>Diastolic BP (mm Hg)</td>
<td>90.0 ± 3.2</td>
<td>72.0 ± 2.0<sup><xref ref-type="table-fn" rid="table-fn3-1933719111424434">b</xref></sup>
</td>
<td>70.0 ± 0.6<sup><xref ref-type="table-fn" rid="table-fn3-1933719111424434">b</xref></sup>
</td>
</tr>
<tr>
<td>Proteinuria</td>
<td>Positive all (1+ to 3+)</td>
<td>Negative all</td>
<td>Negative all</td>
</tr>
<tr>
<td>Edema</td>
<td>Positive all (1+ to 2+)</td>
<td>Negative all</td>
<td>Negative all</td>
</tr>
<tr>
<td>History of illness</td>
<td>None</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>Medication</td>
<td>None</td>
<td>None</td>
<td>None</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1933719111424434">
<p>Abbreviations: BP, blood pressure, NP, normal pregnant participants, NS, nonpregnant participants, PE, participants with preeclampsia; SEM, standard error of the mean.</p>
</fn>
<fn id="table-fn2-1933719111424434">
<p>
<sup>a</sup> Data are shown as mean ± SEM</p>
</fn>
<fn id="table-fn3-1933719111424434">
<p>
<sup>b</sup> <italic>P</italic> &lt; .05 compared to PE participants.</p>
</fn>
<fn id="table-fn4-1933719111424434">
<p>
<sup>c</sup> <italic>P</italic> &lt; .05 compared to NP participants. </p>
</fn>
<fn id="table-fn5-1933719111424434">
<p>
<sup>d</sup> Kruskal-Wallis test followed by Dunn multiple comparison test, except for Gestational age where Mann-Whitney <italic>U</italic> test was used.</p>
</fn>
<fn id="table-fn6-1933719111424434">
<p>
<sup>e</sup> Gestational age at blood collection.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section5-1933719111424434">
<title>Plasma Collection</title>
<p>A blood sample of 10 mL, collected in a sterile plastic tube containing sodium heparin, was obtained from a peripheral vein of a participant in supine position. The samples were then centrifuged at 2500<italic>g</italic> for 25 minutes. Plasma was collected using sterile techniques and then frozen at −40°C until use. Plasma from participants of the same group was tested separately (no plasma pooling).</p>
</sec>
<sec id="section6-1933719111424434">
<title>Umbilical Cords</title>
<p>Umbilical cords were randomly collected after normal delivery from NP women, who were admitted at the Department of Obstetrics and Gynecology, Siriraj Hospital, Bangkok. These participants did not have a history of any disease prior to and during pregnancy, as ascertained by an obstetrician. Cord donors were anonymous and were not included in the NP plasma donor group. Seven cords were needed for each cell preparation. There were altogether 20 cell preparations (preps). In earlier experiments, cells from 1 prep were treated with plasma from 1 participant. However, to ascertain that the disparity in results was due to different plasma treatment and not differences in cell preps, in later experiments cells from the same prep were divided into groups, each treated with plasma from 1 participant (see <xref ref-type="table" rid="table2-1933719111424434">Table 2</xref> for details).</p>
<table-wrap id="table2-1933719111424434" position="float">
<label>Table 2.</label>
<caption>
<p>Comparison of Current Density and Amplitude Among Cell Groups<sup><xref ref-type="table-fn" rid="table-fn9-1933719111424434">a</xref></sup>
</p>
</caption>
<graphic alternate-form-of="table2-1933719111424434" xlink:href="10.1177_1933719111424434-table2.tif"/>
<table>
<thead>
<tr>
<th>Group</th>
<th>Prep</th>
<th>N<sub>total</sub>
</th>
<th>N<sub>in</sub>
</th>
<th>I<sub>in</sub> (−100 mV)</th>
<th>N<sub>out</sub>
</th>
<th>I<sub>out</sub> (+60 mV)</th>
</tr>
</thead>
<tbody>
<tr>
<td>FBS treated</td>
<td>9</td>
<td>29</td>
<td>12</td>
<td>−0.96 <underline>±</underline> 0.17 pA/pF (−18.50 <underline>±</underline> 2.65 pA)</td>
<td>28</td>
<td>3.21 <underline>+</underline> 0.78 pA/pF (58.42 <underline>+</underline> 9.31 pA)</td>
</tr>
<tr>
<td>NS treated</td>
<td>8<sup><xref ref-type="table-fn" rid="table-fn10-1933719111424434">b</xref></sup>
</td>
<td>22</td>
<td>13</td>
<td>−1.22 <underline>±</underline> 0.27 pA/pF (−31.15 <underline>±</underline> 6.67 pA)</td>
<td>18</td>
<td>6.23 <underline>±</underline> 2.08 pA/pF (66.98 <underline>±</underline> 10.01 pA)</td>
</tr>
<tr>
<td>NP treated</td>
<td>3<sup><xref ref-type="table-fn" rid="table-fn10-1933719111424434">b</xref></sup>
</td>
<td>13</td>
<td>10</td>
<td>−1.54 + 0.41 pA/pF (−36.84 + 10.36 pA)</td>
<td>11</td>
<td>3.05 + 0.81 pA/pF (78.19 + 20.08 pA)</td>
</tr>
<tr>
<td>PE treated</td>
<td>5<sup><xref ref-type="table-fn" rid="table-fn10-1933719111424434">b</xref></sup>
</td>
<td>17</td>
<td>7</td>
<td>−1.40 <underline>±</underline> 0.31 pA/pF (−40.10 <underline>±</underline> 7.77 pA)</td>
<td>17</td>
<td>2.75 <underline>±</underline> 0.48 pA/pF (55.33 <underline>±</underline> 8.28 pA)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn25-1933719111424434">
<p>Abbreviations: Prep, number of cord preparations (from normal pregnancy; cord donor participants were not plasma donors; each prep came from 7 cords); N<sub>total</sub>, total number of cells in the group; N<sub>out</sub>, N<sub>in</sub>, number of cells with outward and inward currents, respectively; I<sub>out</sub>, I<sub>in</sub>, outward and inward current, respectively; SEM, standard error of the mean; ANOVA, analysis of variance; FBS, fetal bovine serum; NP, normal pregnant participants, NS, nonpregnant participants, PE, participants with preeclampsia; pA, picoampere (10<sup>-12</sup> ampere); pF, picofarad (10<sup>-12</sup> farad).</p>
</fn>
<fn id="table-fn8-1933719111424434">
<p>Values in I<sub>in</sub> and I<sub>out</sub> columns were mean <underline>±</underline> SEM; both current density (pA/pF) and amplitude (pA, in parentheses) are shown. No significant difference was found among groups in both current density and amplitude (1-way ANOVA with Bonferroni test).</p>
</fn>
<fn id="table-fn9-1933719111424434">
<p>
<sup>a</sup> In 5 preps, cells were divided into 2 groups and treated with different plasmas: 2 preps compared FBS vs NS plasmas; two compared NP vs PE plasmas; and 1 compared NS vs PE plasmas.</p>
</fn>
<fn id="table-fn10-1933719111424434">
<p>
<sup>b</sup>Plasmas from 4 NS participants were divided for treating cells from 8 preps. Similarly, plasmas from 5 NP and 5 PE participants were used to treat 3 and 5 cell preps, respectively. Plasmas were not pooled and cells were divided into groups before being treated with each plasma.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section7-1933719111424434">
<title>Isolation and Culture of HUVECs</title>
<p>The isolation procedure followed that of Akarasereenont,<sup>
<xref ref-type="bibr" rid="bibr28-1933719111424434">28</xref>
</sup> which had been modified from Jaffe et al.<sup>
<xref ref-type="bibr" rid="bibr29-1933719111424434">29</xref>
</sup> Except where noted, all solutions and reagents in this procedure were obtained through Gibco Laboratories, Detroit, Michigan. When necessary, culture solutions were made with sterile, double-distilled water.</p>
<p>After birth, umbilical cords were immediately placed in cold normal saline solution and kept refrigerated until use. Cell isolation procedure in sterile environment was carried out within 24 hours after cord severing. First, after traumatized or damaged areas were trimmed off, the cords were cleaned with phosphate-buffered saline (PBS), containing (in mmol/L) 138 NaCl, 2.7 KCl, 8 Na<sub>2</sub>HPO<sub>4</sub>, and 1.46 KH<sub>2</sub>PO<sub>4</sub> to remove all traces of blood. Then ECs were isolated from umbilical veins with 0.05% trypsin-EDTA solution containing 0.05% trypsin and 0.53 mmol/L EDTA in PBS. After 20 minutes, M199 medium (Hyclone, Logan, Utah) with 10% FBS was added to inhibit any further enzymatic activity that will damage the cells. Isolated cells were grown on glass cover slips (about 2-3 mm × 12 mm) placed in petri dishes containing EC serum-free medium (EC-SFM; Gibco-brl, Grand Island, New York) and M199 (1:1 volume/volume [v/v]), with added 100 IU/mL penicillin, 100 µg/mL streptomycin, and 10% FBS. Finally, the culture was maintained at 37°C in humidified air with 5% CO<sub>2</sub>/95% air. The culture medium was renewed after 24 hours, and then every 2 to 3 days. When ECs in culture became confluent, they were subcultured using 0.05% trypsin-EDTA. The time interval between subcultures was 7 days. Since the success rate for whole-cell access was low in the first-passage cells in preliminary studies, only cells in the second and third passages were used.</p>
</sec>
<sec id="section8-1933719111424434">
<title>Solutions and Chemicals</title>
<p>The external (bath) solution contained (mmol/L) 150 NaCl, 5.9 KCl, 1 CaCl<sub>2</sub>, 1.2 MgCl<sub>2</sub>, 11.5 HEPES, and 10 glucose; pH 7.3 (adjusted with NaOH), 335 mOsmol/kg. The internal (pipette) solution contained (mmol/L) 100 K-aspartate, 40 KCl, 5.5 MgCl<sub>2</sub>, 5 Na<sub>2</sub>ATP, 0.1 EGTA, and 10 HEPES or 1 EGTA and 0.729 CaCl<sub>2</sub> (free [Ca<sup>2+</sup>] = 1 µmol/L, for activating calcium-activated potassium channels); pH 7.2 (adjusted with KOH, 290 mOsmol/kg). The Na<sub>2</sub>ATP was added just before use and unused internal solution was stored on ice during an experiment to prevent ATP degradation. Channel blockers were added to the external solution to identify the types of potassium currents. These were 5 mmol/L tetraethylammonium (TEA), 2 mmol/L BaCl<sub>2</sub>, 200 nmol/L iberiotoxin, and 100 nmol/L apamin. All reagents were purchased from Sigma-Aldrich Pte, Ltd, Singapore. Deionized water was used to prepare all solutions.</p>
</sec>
<sec id="section9-1933719111424434">
<title>Electrophysiological Measurements</title>
<p>All experiments were carried out at 26°C to 28°C, with the whole-cell configuration of the patch clamp technique,<sup>
<xref ref-type="bibr" rid="bibr30-1933719111424434">30</xref>
</sup> using an Axopatch 200A patch clamp amplifier (Axon Instruments, Molecular Devices, Sunnyvale, California). Pipettes were pulled from Kimax-51 capillary tubes (Kimble, Vineland, New Jersey). The pipette resistance was 2 to 4 Mohm when filled with internal solutions. External solutions with or without blockers were applied continuously by a gravity-driven flow system (flow rate = 0.8 mL/min). At the time of the experiment, a cover slip with HUVECs attached was transferred to the recording chamber. Junction potentials were routinely eliminated. Whole-cell capacitance and series resistance were determined after whole-cell access, using the whole-cell capacity transient cancellation circuit of the patch clamp amplifier. The maximum voltage error in our experiments was less than 3%. At least 2-minute equilibration time was allowed before recording after a solution change.</p>
<p>Pulses (200 ms, 1 Hz) were stepped from a holding potential of −40 mV to a potential starting from −100 to +100 mV in 20 mV increments, to obtain a current–voltage relationship (IV curve). In some experiments, only the currents at −100 and +60 mV were elicited to minimize the premature loss of gigaseal. Current signals were filtered at 5 kHz and then digitized at a sampling rate of 4 kHz (Digidata 1200, Axon Instruments). Data were displayed and analyzed by pCLAMP 6 software (Axon Instruments). Leak subtraction was done off-line. For analysis of the current amplitude, only current response at −100 mV and +60 mV (for inward and outward current components, respectively) were used. Current density was calculated by dividing the current amplitude at −100 mV and +60 mV by whole-cell capacitance.</p>
</sec>
<sec id="section10-1933719111424434">
<title>Statistical Analysis</title>
<p>Data are represented as mean <underline>±</underline> standard error of the mean (SEM). Kolmogorov-Smirnov test was applied to all data for testing normality. The difference in cell capacitance among groups was analyzed by 1-way analysis of variance (ANOVA), followed by Bonferroni Multiple Comparison Test. The difference in the number of cells having inward or outward currents among groups was compared using chi-square test. The difference in maximum amplitude and current density between control and test conditions, as well as percentage blocked compared to control current, was compared using either Student <italic>t</italic> test or Wilcoxon signed-rank test, as appropriate. Kruskal-Wallis test, with post hoc Dunn multiple comparison test, was employed to compare the effects of blockers among 4 groups of HUVECs and to compare the age, weight, and blood pressure of plasma donors in PE, NP, and NS groups. Statistical significance was reached when <italic>P</italic> <underline>≤</underline> .05.</p>
</sec>
</sec>
<sec id="section11-1933719111424434">
<title>Results</title>
<p>The HUVECs from all groups were similar in morphology when observed from a phase contrast microscope. No statistically significant difference was found in the whole-cell capacitance among FBS-, NS-, NP- and PE-treated cell groups (20.50 <underline>±</underline> 1.55, 22.51 <underline>±</underline> 1.82, 25.71 <underline>±</underline> 1.75 and 22.68 <underline>±</underline> 1.93 pF (10<sup>-12</sup> farad); n = 40, 39, 14, and 19, respectively; <italic>P</italic> &gt; .05, 1-way ANOVA with Bonferroni test).</p>
<sec id="section12-1933719111424434">
<title>Inward and Outward Components of Whole-Cell Currents</title>
<p>The membrane currents in HUVECs were readily distinguishable into inward and outward current components, which were well separated from each other. <xref ref-type="fig" rid="fig1-1933719111424434">Figure 1</xref> shows examples of current traces and corresponding current–voltage (IV) curves from HUVECs with inward current (A), outward current (B) and both (C). The inward current component was elicited at membrane potentials of −60 mV or more negative, with strong inward rectification and was completely blocked by 2 mmol/L Ba<sup>2+</sup> (<xref ref-type="fig" rid="fig2-1933719111424434">Figure 2A</xref>). These findings strongly indicate that the IRK was responsible for the inward current component in HUVECs. There was no difference in the mean inward current amplitude and density at −100 mV among cell groups (<xref ref-type="table" rid="table2-1933719111424434">Table 2</xref>).</p>
<fig id="fig1-1933719111424434" position="float">
<label>Figure 1.</label>
<caption>
<p>Membrane currents of human umbilical vein endothelial cells. Representative tracings (left panel) and corresponding current–voltage relationship (IV curves; right panel) recorded from cells with inward currents (A), outward currents (B) and both types of currents (C).</p>
</caption>
<graphic alternate-form-of="fig1-1933719111424434" xlink:href="10.1177_1933719111424434-fig1.tif"/>
</fig>
<fig id="fig2-1933719111424434" position="float">
<label>Figure 2.</label>
<caption>
<p>A, The right bar graph shows percentage of inward current density (at −100 mV) remaining after exposure to 2 mmol/L Ba<sup>2+</sup> (n = 2). B-D, Right bar graphs are percentages of outward current density remaining after inhibition by 5 mmol/L tetraethylammonium (TEA; 42.1% <underline>±</underline> 6.9%; n = 5; <italic>P</italic> <underline>≤</underline> .05, Wilcoxan signed rank test), 100 nmol/L apamin (41.9% <underline>±</underline> 5.1%; n = 15; <italic>P</italic> <underline>≤</underline> .01, 1-sample <italic>t</italic> test), and 200 nmol/L iberiotoxin (44.9 <underline>±</underline> 6.7; n = 14; <italic>P</italic> <underline>≤</underline> .01, 1-sample <italic>t</italic> test), respectively (*<italic>P</italic> <underline>≤</underline> .05; **<italic>P</italic> <underline>≤</underline> .01). Error bars represent standard error of the mean (SEM).</p>
</caption>
<graphic alternate-form-of="fig2-1933719111424434" xlink:href="10.1177_1933719111424434-fig2.tif"/>
</fig>
<p>The outward current component in these cells, on the other hand, was elicited by potentials of 0 mV or more positive, increasing with membrane depolarization. This current component was partially blocked by 5 mmol/L TEA, 100 nmol/L apamin, and 200 nmol/L iberiotoxin (<xref ref-type="fig" rid="fig2-1933719111424434">Figure 2 B, C</xref>, and <xref ref-type="fig" rid="fig2-1933719111424434">D</xref>), indicating that the outward current component could be partially attributed to the small and large conductance calcium-activated potassium currents (SK<sub>Ca</sub> and BK<sub>Ca</sub>). There was no significant difference in the mean outward current amplitude and density at +60 mV among groups (<xref ref-type="table" rid="table2-1933719111424434">Table 2</xref>). The percentage of apamin- and iberiotoxin-sensitive currents compared to total outward current at +60 mV was not different among cell groups (<italic>P</italic> &gt; .05; Kruskal-Wallis test; data not shown).</p>
</sec>
<sec id="section13-1933719111424434">
<title>Fractions of Cells With Inward and Outward Current Components</title>
<p>Although the current amplitude and density of both the inward and the outward current components were not different among cell groups, there were variations in the proportion of cells expressing each current component. The fraction of cells with inward component in FBS-, NS-, NP- and PE-treated cell groups were 41.3% (12 of 29), 59.1% (13 of 22), 76.9% (10 of 13), and 41.2% (7 of 17), respectively (<xref ref-type="fig" rid="fig3-1933719111424434">Figure 3A</xref>). Normal pregnant-treated cell group had significantly larger fraction of cells with inward current (or the IRK) than either PE- or FBS-treated cell group (<italic>P</italic> <underline>≤</underline> .05 and <underline>≤</underline> .01, respectively, chi-square test, 1-tailed). The fraction with outward component was 96.5% (28 of 29), 81.8% (18 of 22), 84.6% (11 of 13), and 100% (17 of 17), in the same order as above (<xref ref-type="fig" rid="fig3-1933719111424434">Figure 3B</xref>). Both PE- and FBS-treated cells had similarly high fraction of cells with outward currents, while NP- and NS-treated cells had significantly lower fractions compared to either PE- or FBS-treated cells (NP vs PE, <italic>P</italic> <underline>≤</underline> .01; NP vs FBS, <italic>P</italic> <underline>≤</underline> .05; NS vs PE, <italic>P</italic> <underline>≤</underline> .05; NS vs FBS, <italic>P</italic> <underline>≤</underline> .05; chi-square test, 1-tailed).</p>
<fig id="fig3-1933719111424434" position="float">
<label>Figure 3.</label>
<caption>
<p>Percentage of cells with inward (A) and outward currents (B), comparing FBS-, NS-, NP- and PE-treated cells. *<italic>P</italic> <underline>≤</underline> .05; **<italic>P</italic> <underline>≤</underline> .01. (Cells with both currents were counted in both panels.) See text for details. FBS indicates fetal bovine serum; NS, nonpregnant; NP, normal pregnant; PE, preeclampsia.</p>
</caption>
<graphic alternate-form-of="fig3-1933719111424434" xlink:href="10.1177_1933719111424434-fig3.tif"/>
</fig>
</sec>
</sec>
<sec id="section14-1933719111424434">
<title>Discussion</title>
<sec id="section15-1933719111424434">
<title>The Effects of Preeclamptic Plasma on Potassium Channels</title>
<p>The most important finding in the present study was that the fraction of cells with inward currents in PE-treated cells was significantly lower compared to NP-treated cells (<xref ref-type="fig" rid="fig3-1933719111424434">Figure 3A</xref>). The inward current component in this study could be attributed entirely to the IRK, by the characteristic IV curve (<xref ref-type="fig" rid="fig1-1933719111424434">Figure 1A</xref> and  <xref ref-type="fig" rid="fig1-1933719111424434">C</xref>) and the complete block by 2 mmol/L Ba<sup>2+</sup> (<xref ref-type="fig" rid="fig2-1933719111424434">Figure 2A</xref>). Therefore, the lower fraction of PE-treated cells with inward current compared to NP-treated cells may be interpreted as the presence of a factor, or lack of one, in the PE plasma, which may reduce the number of cells with IRK in HUVECs. Since IRK is well known as one of the most important channels for the control of the resting membrane potential in ECs,<sup>
<xref ref-type="bibr" rid="bibr22-1933719111424434">22</xref>
</sup> IRK impairment or downregulation may result in EC dysfunction. Decreased IRK currents could depolarize the cell membrane by decreasing potassium permeability, thereby reducing the driving force for Ca<sup>2+</sup> influx. This may decrease the EC production of vasodilator, such as nitric oxide (NO) and prostacyclin,<sup>
<xref ref-type="bibr" rid="bibr31-1933719111424434">31</xref>
<xref ref-type="bibr" rid="bibr32-1933719111424434"/>–<xref ref-type="bibr" rid="bibr33-1933719111424434">33</xref>
</sup> leading to widespread vasoconstriction seen in PE.</p>
<p>Interestingly, the finding in this study that PE-treated cells had a lower fraction of IRK than NP-treated cells may be complementary to our preliminary data that the IRK current density was significantly decreased in HUVECs of patients with PE to about half of that from normal cords, indicating a reduction in the expression of IRK in preeclamptic HUVECs in culture.<sup>
<xref ref-type="bibr" rid="bibr34-1933719111424434">34</xref>
</sup> Together, these data could indicate that patients with PE may not only be deficient in IRK (a possible genetic involvement), but have some factors existing in maternal plasma that affect the function or the expression of IRK, resulting in the loss of function or downregulation of IRK. Indeed, the pathogenesis of PE could be multifactorial.<sup>
<xref ref-type="bibr" rid="bibr4-1933719111424434">4</xref>
<xref ref-type="bibr" rid="bibr5-1933719111424434"/>–<xref ref-type="bibr" rid="bibr6-1933719111424434">6</xref>
</sup>
</p>
<p>The outward current component could be elicited at membrane potentials of 0 mV or more positive, increasing with membrane depolarization, and partially blocked by 100 nmol/L apamin and 200 nmol/L iberiotoxin with no significant difference in the percentage blocked among groups. These data suggest that the outward current components in all 4 groups could be attributed to both small and large conductance calcium-activated potassium channels (SK<sub>Ca</sub> and BK<sub>Ca</sub>),<sup>
<xref ref-type="bibr" rid="bibr35-1933719111424434">35</xref>
<xref ref-type="bibr" rid="bibr36-1933719111424434"/>–<xref ref-type="bibr" rid="bibr37-1933719111424434">37</xref>
</sup> with no intergroup difference in the proportional expression of both channels, indicating the lack of effect of PE plasma on the relative contribution of SK<sub>Ca</sub> and BK<sub>Ca</sub>.</p>
<p>Another interesting finding was that PE-treated cells had significantly larger proportion of cells with outward currents than NP-treated cells. This can be interpreted in several ways. Preeclamsia-treated cells could have higher proportion of outward current, thus may be able to increase the driving force for Ca<sup>2+</sup> during Ca<sup>2+</sup> influx, a change in the opposite direction to that expected for a pathogenetic mechanism of PE. Alternatively, this may simply be a manifestation of the lower proportion of IRK or it may actually be a compensatory response of HUVECs, whose IRK have been reduced. A previous study suggested an interesting association between decreased IRK and increased K<sub>Ca</sub> currents in HUVECs caused by hydrogen peroxide.<sup>
<xref ref-type="bibr" rid="bibr38-1933719111424434">38</xref>
</sup> The latter is produced by oxidative stress, a candidate mechanism resulting from ischemic placenta that may cause PE. Furthermore, oxidized low-density lipoprotein, known to cause EC dysfunction and enhanced hydrogen peroxide production, was suggested to activate BK<sub>Ca</sub> channels in HUVECs.<sup>
<xref ref-type="bibr" rid="bibr39-1933719111424434">39</xref>
</sup>
</p>
<sec id="section16-1933719111424434">
<title>Similarity between PE-treated and FBS-treated cells</title>
<p>Our results also showed that the fractions of cells having inward and outward currents in PE-treated cells were similar to those in FBS-treated cells, although they were significantly different from those in NP-treated cells. On the other hand, the fractions of cells with inward and outward currents in NS- and NP-treated cells were not significantly different from each other (<xref ref-type="fig" rid="fig3-1933719111424434">Figure 3</xref>). This might imply that the plasma of NP participants was not different, in terms of its effect on HUVEC ion channels, compared to NS participants, while preeclamptic plasma altered the fraction of cells with channels. Possibly, there might be some substances present (or absent) in both preeclamptic plasma and FBS that inhibited IRK and/or increased the outward current component. Additionally, these results might raise some questions whether using FBS in cell culture adequately approximates physiological conditions.</p>
</sec>
</sec>
<sec id="section17-1933719111424434">
<title>Preeclamptic Plasma and Endothelial Dysfunctions</title>
<p>The existence of pathogenic factors in either plasma or serum from patients with PE capable of altering endothelial functions has been suggested in many reports.<sup>
<xref ref-type="bibr" rid="bibr15-1933719111424434">15</xref>
<xref ref-type="bibr" rid="bibr16-1933719111424434"/>
<xref ref-type="bibr" rid="bibr17-1933719111424434"/>
<xref ref-type="bibr" rid="bibr18-1933719111424434"/>
<xref ref-type="bibr" rid="bibr19-1933719111424434"/>
<xref ref-type="bibr" rid="bibr20-1933719111424434"/>–<xref ref-type="bibr" rid="bibr21-1933719111424434">21</xref>,<xref ref-type="bibr" rid="bibr40-1933719111424434">40</xref>
</sup> Several candidate molecules have been proposed as the culprit for endothelial dysfunction in PE, such as lipid peroxides, cytokine interleukin 8 (IL-8),<sup>
<xref ref-type="bibr" rid="bibr41-1933719111424434">41</xref>
</sup> IL-1, and IL-6.<sup>42,43</sup> More recent evidence has pointed to novel soluble mediators, most notably the soluble FMS-like tyrosine kinase 1 (sFlt-1).<sup>40,44-48</sup> Interestingly, sFlt-1 can cause impairment of NO synthesis,<sup>49</sup> an endothelial function dependent on cell membrane potential and K<sup>+</sup> channel functions. It is intriguing, therefore, to test whether the same alterations in endothelial K<sup>+</sup> channel could be elicited by cell exposure to sFlt-1, or other proposed pathogenic molecules.</p>
</sec>
<sec id="section18-1933719111424434">
<title>Limitations</title>
<p>It should be pointed out that HUVECs in our experiments should be regarded as merely a test system for comparing the effects of various plasmas on endothelial ion channels. These were cells of fetal origin and may not represent maternal ECs in all aspects. It is known that endothelial ion channel expression may vary according to the vessel’s size (whether they are micro- or macrovascular) and site (the vascular bed they have been derived from).<sup>
<xref ref-type="bibr" rid="bibr22-1933719111424434">22</xref>
</sup> Moreover, ECs in culture may be different from in situ conditions.<sup>
<xref ref-type="bibr" rid="bibr22-1933719111424434">22</xref>,<xref ref-type="bibr" rid="bibr50-1933719111424434">50</xref>,<xref ref-type="bibr" rid="bibr51-1933719111424434">51</xref>
</sup> For example, IRK expression was shown to increase in cultured HUVECs compared to freshly dissociated cells.<sup>
<xref ref-type="bibr" rid="bibr22-1933719111424434">22</xref>,<xref ref-type="bibr" rid="bibr51-1933719111424434">51</xref>
</sup> We minimized the heterogeneity of the culture system using cells in limited passages (only passages 2 and 3) and recording only between 5 and 14 hours after plating. Analysis of the correlation between inward or outward current density (I<sub>in</sub> or I<sub>out</sub>; pooled data) versus time after plating showed no correlation (I<sub>in</sub>, <italic>r</italic> = −.2740, <italic>P</italic> = .5114; I<sub>out</sub>, <italic>r</italic> = −.2193, <italic>P</italic> = .2442; Pearson correlation). Likewise, current density in a group was not correlated with time after plating (eg, FBS-treated cell groups: I<sub>in</sub>, <italic>r</italic> = .0003, <italic>P</italic> = .9996; I<sub>out</sub>, <italic>r</italic> = −.0729, <italic>P</italic> = .7963). Finally, it is possible that the variation in the number of successful recordings obtained per prep (N<sub>total</sub> in <xref ref-type="table" rid="table2-1933719111424434">Table 2</xref>) could have partially contributed to the difference in the currents among groups.</p>
<p>Using HUVECs derived only from normal pregnancy and within a well-defined time window in culture, we demonstrated that plasmas from mother with PE could alter the fraction of cells expressing IRK channels, a result consistent with the presence (or absence) of a soluble substance in preeclamptic plasma. In addition, the present evidence provides a possible mechanism of maternal endothelial dysfunction seen clinically. It remains to be further tested whether this actually happens in vivo.</p>
</sec>
</sec>
<sec id="section19-1933719111424434">
<title>Conclusions</title>
<p>Data from this study suggest endothelial K<sup>+</sup> channels as a possible target of a soluble pathogenic factor in preeclamptic plasma, which may participate in the pathogenesis of PE. In addition, our results support the existence of soluble factors present in preeclamptic plasma which can reduce the proportion of cells with IRK and/or increase those with K<sub>Ca</sub> currents. On the other hand, it is also possible that the preeclamptic plasma may lack some factors that maintain IRK or inhibited SK<sub>Ca</sub> and BK<sub>Ca</sub>. Previously reported evidence in the literature, which is based mostly on studies on the effect of serum or plasma from PE participants on vasoactive substance release, may support the former hypothesis.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We are grateful to Athiwat Thaworn, Duanguan Boonthong Siriwittayawan, and Kallaya Chanwongse for excellent technical assistance.</p>
</ack>
<fn-group>
<fn fn-type="other" id="fn1-1933719111424434">
<p>This work was carried out in the Departments of Physiology, Pharmacology, and Obstetrics–Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok.</p>
</fn>
<fn fn-type="conflict" id="fn2-1933719111424434">
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn3-1933719111424434">
<p>The study was supported by the Faculty of Medicine Siriraj Hospital, Mahidol University (WBW) and the National Science and Technology Development Agency (NSTDA) (WT).</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1933719111424434">
<label>1</label>
<citation citation-type="journal">
<collab collab-type="author">World Health Organization International Collaborative Study of Hypertensive Disorder of Pregnancy</collab>. <article-title>Geographic variation in the incidence of hypertension</article-title>. <source>Am J Obstet Gynecol</source>. <year>1998</year>;<volume>158</volume>(<issue>1</issue>):<fpage>80</fpage>–<lpage>83</lpage>.</citation>
</ref>
<ref id="bibr2-1933719111424434">
<label>2</label>
<citation citation-type="journal">
<collab collab-type="author">ACOG</collab>. <article-title>Diagnosis and management of preclampsia and eclampsia</article-title>. <source>ACOG Pract Bull</source>. <year>2002</year>;<volume>33</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>14</lpage>.</citation>
</ref>
<ref id="bibr3-1933719111424434">
<label>3</label>
<citation citation-type="book">
<collab collab-type="author">World Health Organization</collab>. <source>World Health Report: Make Every Mother, and Child Count</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Org</publisher-name>., <year>2005</year>.</citation>
</ref>
<ref id="bibr4-1933719111424434">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>VanWijk</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Kublickiene</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Boer</surname>
<given-names>K</given-names>
</name>
<name>
<surname>VanBavel</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Vascular function in preeclampsia</article-title>. <source>Cardiovasc Res</source>. <year>2000</year>;<volume>47</volume>(<issue>1</issue>):<fpage>38</fpage>–<lpage>48</lpage>.</citation>
</ref>
<ref id="bibr5-1933719111424434">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noris</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Perico</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Remuzzi</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Mechanisms of disease: preeclampsia</article-title>. <source>Nat Clin Pract Nephrol</source>. <year>2005</year>;<volume>1</volume>(<issue>2</issue>):<fpage>98</fpage>–<lpage>114</lpage>.</citation>
</ref>
<ref id="bibr6-1933719111424434">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rana</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Karumanchi</surname>
<given-names>SA</given-names>
</name>
</person-group>. <article-title>Preeclampsia: the role of angiogenic factors in its pathogenesis</article-title>. <source>Physiology</source>. <year>2009</year>;<volume>24</volume>(<issue>3</issue>):<fpage>147</fpage>–<lpage>158</lpage>.</citation>
</ref>
<ref id="bibr7-1933719111424434">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khalil</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Crews</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Novax</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kassab</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Granger</surname>
<given-names>JP</given-names>
</name>
</person-group>. <article-title>Enhanced vascular activity during inhibition of nitric oxide synthesis in pregnant rats</article-title>. <source>Hypertension</source>. <year>1998</year>;<volume>31</volume>(<issue>5</issue>):<fpage>1065</fpage>–<lpage>1069</lpage>.</citation>
</ref>
<ref id="bibr8-1933719111424434">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roberts</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Musci</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Rodgers</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Hubel</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>McLaughlin</surname>
<given-names>MK</given-names>
</name>
</person-group>. <article-title>Preeclampsia: an endothelial cell disorder</article-title>. <source>Am J Obstet Gynecol</source>. <year>1989</year>;<volume>161</volume>(<issue>5</issue>):<fpage>1200</fpage>–<lpage>1204</lpage>.</citation>
</ref>
<ref id="bibr9-1933719111424434">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Trudinger</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Endothelial cell dysfunction in preeclampsia</article-title>. <source>J Nephrol</source>. <year>1998</year>;<volume>11</volume>(<issue>2</issue>):<fpage>53</fpage>–<lpage>56</lpage>.</citation>
</ref>
<ref id="bibr10-1933719111424434">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilbert</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>LaMarca</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Sedeek</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Murpht</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Granger</surname>
<given-names>JP</given-names>
</name>
</person-group>. <article-title>Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction</article-title>. <source>Am J Physiol Heart Circ Physiol</source>. <year>2008</year>;<volume>294</volume>(<issue>2</issue>):<fpage>H541</fpage>–<lpage>H550</lpage>.</citation>
</ref>
<ref id="bibr11-1933719111424434">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Myatt</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Webster</surname>
<given-names>RP</given-names>
</name>
</person-group>. <article-title>Vascular biology of preeclampsia</article-title>. <source>J Thromb Heamatost</source>. <year>2009</year>;<volume>7</volume>(<issue>3</issue>):<fpage>375</fpage>–<lpage>384</lpage>.</citation>
</ref>
<ref id="bibr12-1933719111424434">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chambers</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Fusi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Malik</surname>
<given-names>IS</given-names>
</name>
<name>
<surname>Haskard</surname>
<given-names>DO</given-names>
</name>
<name>
<surname>De Swiet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kooner</surname>
<given-names>JS</given-names>
</name>
</person-group>. <article-title>Association of maternal endothelial dysfunction with preeclampsia</article-title>. <source>JAMA</source>. <year>2001</year>;<volume>285</volume>(<issue>12</issue>):<fpage>1607</fpage>–<lpage>1612</lpage>.</citation>
</ref>
<ref id="bibr13-1933719111424434">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Germain</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Romanik</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Guerra</surname>
<given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events?</article-title> <source>Hypertens</source>. <year>2007</year>;<volume>49</volume>(<issue>1</issue>):<fpage>90</fpage>–<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr14-1933719111424434">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agatisa</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Ness</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Costantino</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Kuller</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Mclaughlin</surname>
<given-names>MK</given-names>
</name>
</person-group>. <article-title>Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk</article-title>. <source>Am J Physiol Heart Circ Physiol</source>. <year>2004</year>;<volume>286</volume>(<issue>4</issue>):<fpage>H1389</fpage>–<lpage>H1393</lpage>.</citation>
</ref>
<ref id="bibr15-1933719111424434">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baker</surname>
<given-names>PN</given-names>
</name>
<name>
<surname>Davidge</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Barankiewic</surname>
<given-names>ZJ</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>JM</given-names>
</name>
</person-group>. <article-title>Plasma of preeclamptic women stimulates and then inhibits endothelial prostacyclin</article-title>. <source>Hypertension</source>. <year>1996</year>;<volume>27</volume>(<issue>1</issue>):<fpage>56</fpage>–<lpage>61</lpage>.</citation>
</ref>
<ref id="bibr16-1933719111424434">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinto</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sorrentino</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sorrentino</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension</article-title>. <source>Am J Obstet Gynecol</source>. <year>1991</year>;<volume>164</volume>(<issue>2</issue>):<fpage>507</fpage>–<lpage>513</lpage>.</citation>
</ref>
<ref id="bibr17-1933719111424434">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodgers</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>JM</given-names>
</name>
</person-group>. <article-title>Preeclampsia is associated with a serum factor cytotoxic to human endothelial cell</article-title>. <source>Am J Obstet Gynecol</source>. <year>1998</year>;<volume>159</volume>(<issue>4</issue>):<fpage>908</fpage>–<lpage>914</lpage>.</citation>
</ref>
<ref id="bibr18-1933719111424434">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scalera</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Schlembach</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Beinder</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Production of vasoactive substances by human umbilical vein endothelial cells after incubation with serum from preeclamptic patients</article-title>. <source>Eur J Obstet Gynecol Reprod Biol</source>. <year>2001</year>;<volume>99</volume>(<issue>2</issue>):<fpage>172</fpage>–<lpage>178</lpage>.</citation>
</ref>
<ref id="bibr19-1933719111424434">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smarason</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Sargent</surname>
<given-names>IL</given-names>
</name>
<name>
<surname>Redman</surname>
<given-names>CW</given-names>
</name>
</person-group>. <article-title>Endothelial cell proliferation is suppressed by plasma but not serum from women with preeclampsia</article-title>. <source>Am J Obstet Gynecol</source>. <year>1996</year>;<volume>174</volume>(<issue>2</issue>):<fpage>787</fpage>–<lpage>793</lpage>.</citation>
</ref>
<ref id="bibr20-1933719111424434">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsukimori</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shingu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Koyanagi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nobunaga</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nakano</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>Possible mechanism of vascular damage in preeclampsia</article-title>. <source>J Human Hypertens</source>.<year>1994</year>;<volume>8</volume>(<issue>3</issue>):<fpage>177</fpage>–<lpage>180</lpage>.</citation>
</ref>
<ref id="bibr21-1933719111424434">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maynard</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Merchan</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia</article-title>. <source>J Clin Invest</source>. <year>2003</year>;<volume>111</volume>(<issue>5</issue>):<fpage>649</fpage>–<lpage>658</lpage>.</citation>
</ref>
<ref id="bibr22-1933719111424434">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nilius</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Droogmans</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Ion channels and their functional role in vascular endothelium</article-title> <source>Physiol Rev</source>. <year>2001</year>;<volume>81</volume>(<issue>4</issue>):<fpage>1415</fpage>–<lpage>1459</lpage>.</citation>
</ref>
<ref id="bibr23-1933719111424434">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamouchi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mamin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Droogmans</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nilius</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Nonselective cation channels in endothelial cells derived from human umbilical vein</article-title>. <source>J Membr Biol</source>. <year>1999</year>;<volume>169</volume>(<issue>1</issue>):<fpage>29</fpage>–<lpage>38</lpage>.</citation>
</ref>
<ref id="bibr24-1933719111424434">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nilius</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Oike</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Droogmans</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Histamine-activated, non-selective cation currents and Ca2+ transients in endothelial cells from human umbilical vein</article-title>. <source>Pflugers Arch</source>. <year>1993</year>;<volume>424</volume>(<issue>3-4</issue>):<fpage>285</fpage>–<lpage>293</lpage>.</citation>
</ref>
<ref id="bibr25-1933719111424434">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steinert</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Wyatt</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Poston</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jacob</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>GE</given-names>
</name>
</person-group>. <article-title>Preeclampsia is associated with altered Ca2+ regulation and NO production in human fetal venous endothelial cells</article-title>. <source>FASEB J</source>. <year>2002</year>;<volume>16</volume>(<issue>7</issue>):<fpage>721</fpage>–<lpage>723</lpage>.</citation>
</ref>
<ref id="bibr26-1933719111424434">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Köhler</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schönfelder</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hopp</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Distler</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hoyer</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Stretch-activated cation channel in human umbilical vein endothelium in normal pregnancy and in preeclampsia</article-title>. <source>J Hypertens</source>. <year>1998</year>;<volume>16</volume>(<issue>8</issue>):<fpage>1149</fpage>–<lpage>1156</lpage>.</citation>
</ref>
<ref id="bibr27-1933719111424434">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keichi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hiroshi</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Hirouki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Masaharu</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Keizo</surname>
<given-names>O</given-names>
</name>
</person-group>. <article-title>Ca<sup>++</sup> oscillation in endothelial cell and preclampsia</article-title>. <source>Lancet</source>. <year>1998</year>;<volume>351</volume>(<issue>9114</issue>):<fpage>1490</fpage>–<lpage>1491</lpage>.</citation>
</ref>
<ref id="bibr28-1933719111424434">
<label>28</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Akarasereenont</surname>
<given-names>P</given-names>
</name>
</person-group>. <source>Regulation and Pharmacology of the Inducible Cyclooxygenase (COX-2)</source> <source>[Ph.D. Thesis in Pharmacology]</source>. <publisher-loc>London, UK</publisher-loc>: <publisher-name>University</publisher-name>
<publisher-name> of London</publisher-name>; <year>1995</year>.</citation>
</ref>
<ref id="bibr29-1933719111424434">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaffe</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Nachman</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Minick</surname>
<given-names>CR</given-names>
</name>
</person-group>. <article-title>Culture of human endothelial cells derived from umbilical veins, identification by morphologic and immunologic criteria</article-title>. <source>J Clin Invest</source>. <year>1973</year>;<volume>52</volume>(<issue>11</issue>):<fpage>2745</fpage>–<lpage>2756</lpage>.</citation>
</ref>
<ref id="bibr30-1933719111424434">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamill</surname>
<given-names>OP</given-names>
</name>
<name>
<surname>Marty</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Neher</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sakmann</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sigworth</surname>
<given-names>FJ</given-names>
</name>
</person-group>. <article-title>Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches</article-title>. <source>Pflugers Arch</source>. <year>1981</year>;<volume>391</volume>(<issue>2</issue>):<fpage>85</fpage>–<lpage>100</lpage>.</citation>
</ref>
<ref id="bibr31-1933719111424434">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacobs</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Cheliakine</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gebremedhin</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Birks</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Harder</surname>
<given-names>DR</given-names>
</name>
</person-group>. <article-title>Shear activated channels in cell-attached patches of cultured bovine aortic endothelial cells</article-title>. <source>Pflugers Arch</source>. <year>1995</year>;<volume>431</volume>(<issue>1</issue>):<fpage>129</fpage>–<lpage>131</lpage>.</citation>
</ref>
<ref id="bibr32-1933719111424434">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamouchi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vandenbremt</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Eegermont</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Droogmans</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nilius</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Modulation of inwardly rectifying potassium channels in cultured bovine pulmonary artery endothelial cells</article-title>. <source>J Physiol (Lond)</source>. <year>1997</year>;<volume>507</volume>(<issue>pt 3</issue>):<fpage>545</fpage>–<lpage>556</lpage>.</citation>
</ref>
<ref id="bibr33-1933719111424434">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Himmel</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Rauen</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Ravens</surname>
<given-names>U</given-names>
</name>
</person-group>. <article-title>Microvascular endothelial cells from human omentum lack an inward rectifier K<sup>+</sup> current</article-title>. <source>Physiol Res</source>. <year>2001</year>;<volume>50</volume>(<issue>6</issue>):<fpage>547</fpage>–<lpage>555</lpage>.</citation>
</ref>
<ref id="bibr34-1933719111424434">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanapa</surname>
<given-names>WB</given-names>
</name>
<name>
<surname>Chanwongse</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Akarasereenont</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Techatrisak</surname>
<given-names>K</given-names>
</name>
</person-group>. <article-title>Comparison of endothelial K channels in preeclampsia and normal pregnancy</article-title>. <source>Siriraj Hosp Gaz</source>. <year>2003</year>;<volume>55</volume>(<issue>suppl 1</issue>):<fpage>173</fpage>–<lpage>174</lpage>.</citation>
</ref>
<ref id="bibr35-1933719111424434">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiang</surname>
<given-names>HT</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>SN</given-names>
</name>
</person-group>. <article-title>Inhibition of large-conductance calcium-activated potassium channels by 2-methoxyestradiol in cultured vascular endothelial (HUV-EC-C) cells</article-title>. <source>J Membr Biol</source>. <year>2001</year>;<volume>182</volume>(<issue>3</issue>):<fpage>203</fpage>–<lpage>212</lpage>.</citation>
</ref>
<ref id="bibr36-1933719111424434">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Jan</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>HF</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>SA</given-names>
</name>
</person-group>. <article-title>Stimulation of large-conductance calcium-activated potassium channels by Evan Blue in cultured endothelial cells of human umbilical vein</article-title>. <source>Biochem Biophysic Res Comm</source>. <year>1999</year>;<volume>254</volume>(<issue>3</issue>):<fpage>666</fpage>–<lpage>674</lpage>.</citation>
</ref>
<ref id="bibr37-1933719111424434">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Inazu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Weir</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Daniel</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Endothelin-1 inhibits inward rectifier potassium channels and activates nonspecific cation channels in cultured endothelial cells</article-title>. <source>Pharmacology</source>. <year>1994</year>;<volume>49</volume>(<issue>1</issue>):<fpage>11</fpage>–<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr38-1933719111424434">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bychkov</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pieper</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ried</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Hydrogen peroxide, potassium currents, and membrane potential in human endothelial cells</article-title>. <source>Circulation</source>. <year>1999</year>;<volume>99</volume>(<issue>13</issue>):<fpage>1719</fpage>–<lpage>1725</lpage>.</citation>
</ref>
<ref id="bibr39-1933719111424434">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuhlmann</surname>
<given-names>CRW</given-names>
</name>
<name>
<surname>Schäfer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Modulation of endothelial Ca<sup>2+</sup>-activated K<sup>+</sup> channels by oxidized LDL and its contribution to endothelial proliferation</article-title>. <source>Cardiovasc Res</source>. <year>2003</year>;<volume>60</volume>(<issue>3</issue>):<fpage>626</fpage>–<lpage>634</lpage>.</citation>
</ref>
<ref id="bibr40-1933719111424434">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmad</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia</article-title>. <source>Circ Res</source>. <year>2004</year>;<volume>95</volume>(<issue>9</issue>):<fpage>884</fpage>–<lpage>891</lpage>.</citation>
</ref>
<ref id="bibr41-1933719111424434">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>DF</given-names>
</name>
</person-group>. <article-title>Evidence of endothelial dysfunction in preeclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia</article-title>. <source>Am J Obstet Gynecol</source>. <year>2004</year>;<volume>190</volume>(<issue>3</issue>):<fpage>817</fpage>–<lpage>824</lpage>.</citation>
</ref>
<ref id="bibr42-1933719111424434">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takacs</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Nikaeo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kauma</surname>
<given-names>SW</given-names>
</name>
</person-group>. <article-title>Increased vascular endothelial cell production of interleukin-6 in severe preeclampsia</article-title>. <source>Am J Obstet Gynecol</source>. <year>2003</year>;<volume>188</volume>(<issue>3</issue>):<fpage>740</fpage>–<lpage>744</lpage>.</citation>
</ref>
<ref id="bibr43-1933719111424434">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greer</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Lyall</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Perera</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Boswell</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Macara</surname>
<given-names>LM</given-names>
</name>
</person-group>. <article-title>Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction?</article-title> <source>Obstet Gynecol</source>. <year>1994</year>;<volume>84</volume>(<issue>6</issue>):<fpage>937</fpage>–<lpage>940</lpage>.</citation>
</ref>
<ref id="bibr44-1933719111424434">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shibuya</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis</article-title>. <source>Angiogenesis</source>. <year>2006</year>;<volume>9</volume>(<issue>4</issue>):<fpage>225</fpage>–<lpage>230</lpage>.</citation>
</ref>
<ref id="bibr45-1933719111424434">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>McMaster</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Woo</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome</article-title>. <source>Am J Pathol</source>. <year>2002</year>;<volume>160</volume>(<issue>4</issue>):<fpage>1405</fpage>–<lpage>1423</lpage>.</citation>
</ref>
<ref id="bibr46-1933719111424434">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levine</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Maynard</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Circulating angiogenic factors and the risk of preeclampsia</article-title>. <source>N Engl J Med</source>. <year>2004</year>;<volume>350</volume>(<issue>7</issue>):<fpage>672</fpage>–<lpage>683</lpage>.</citation>
</ref>
<ref id="bibr47-1933719111424434">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKeeman</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Ardill</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Caldwell</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Hunter</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>McClure</surname>
<given-names>N</given-names>
</name>
</person-group>. <article-title>Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop</article-title>. <source>Am</source> <source>
<italic>J Obstet Gynecol</italic>
</source>. <year>2004</year>;<volume>191</volume>(<issue>4</issue>):<fpage>1240</fpage>–<lpage>1246</lpage>.</citation>
</ref>
<ref id="bibr48-1933719111424434">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wathen</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Tuutti</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Stenman</surname>
<given-names>UH</given-names>
</name>
<etal/>
</person-group>. <article-title>Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2006</year>;<volume>91</volume>(<issue>1</issue>):<fpage>180</fpage>–<lpage>184</lpage>.</citation>
</ref>
<ref id="bibr49-1933719111424434">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sandrim</surname>
<given-names>VC</given-names>
</name>
<name>
<surname>Palei</surname>
<given-names>ACT</given-names>
</name>
<name>
<surname>Metzger</surname>
<given-names>IF</given-names>
</name>
<name>
<surname>Gomes</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Cavalli</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Tanus-Santos</surname>
<given-names>JE</given-names>
</name>
</person-group>. <article-title>Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble FMS-like tyrosine kinase-1 and soluble endogline in preeclampsia</article-title>. <source>Hypertens</source>. <year>2008</year>;<volume>52</volume>(<issue>2</issue>):<fpage>402</fpage>–<lpage>407</lpage>.</citation>
</ref>
<ref id="bibr50-1933719111424434">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hewett</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Watts</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Woodcock</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Isolation and characterization of microvessel endothelial cells from human mammary adipose tissue</article-title>. <source>In Vitro Cell Dev Biol</source>. <year>1993</year>;<volume>29</volume>(<issue>4</issue>):<fpage>325</fpage>–<lpage>331</lpage>.</citation>
</ref>
<ref id="bibr51-1933719111424434">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nilius</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Schwarz</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Oike</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Droogmans</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Histamine-activated, non-selective cation currents and Ca21 transients in endothelial cells from human umbilical vein</article-title>. <source>Pflügers Arch</source>. <year>1993</year>;<volume>424</volume>(<issue>3-4</issue>):<fpage>285</fpage>–<lpage>293</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>